SIOPE/ESOP declaration

Children Cancer Day

Pharmacists across the world working with Childhood Cancer observe cancer as a diagnosis that turns the lives of the entire family into chaos of uncertainty.
Pharmacists play an integral role in the clinical decision making aiming to optimize patient experience. Pharmacist in this special day for childhood cancer are renewing their promise to do their best, to update their knowledge and skills to improve the quality of life of our children with cancer and help our families in the journey of cure.
The European society of Oncology Pharmacy believes in unity in diversity and by this are uniting the efforts of oncology pharmacists in more than 40 countries across Europe and the world toward a unified goal of curing our cancer patients with the best quality of life.

In the honor of the day the ESOP launched a Pediatric Oncology Pharmacy Working Group that is going to work with all organizations interested in childhood cancer to:
  • To explore ways to increase pharmacists' body of knowledge of pediatric hematology/oncology
  • To empower pharmacists to participate more effectively in managing hem/oncology patients
  • To develop programs for safe handling of anticancer agents
  • To develop educational resources for pharmacists and nurses managing chemotherapy and other essential medications
  • To create tools to promote appropriate medication management
  • To develop and institutionalize standards for hem/oncology pharmacy practice
  • To develop a Continuing Medical Education program for pharmacists
  • To develop and maintain a culture of patient and professional safety
  • To implement and customize Health Information Technology and pharmacy automation



Code of Conduct

ESOP’s guiding principles with regard to partnerships, sponsorship and conflicts of interest forms the foundation of ESOP’s potential to access funds, services in kind and joint venture operations from public bodies, firms or foundations that this do not contravene the principles and values of ESOP and its members.

It does not aim to provide a definition of every possible funding opportunity or relationship but rather define a set of operating principles.

The guiding principles comply with the objectives and mission of ESOP to support cancer patient best in order to reach the purpose of multiprofessional and interdisciplinary collaboration and education.

Download Code of Conduct



Organisation status and funding sources

Download Funding Sources

Download ESOP Registration non profit organisation



Oral Antineoplastic Therapy Basic Considerations, April 2009

Download



ESOP Ljubljana Declaration 2006


  To the German version »

  Download the Ljubljana Declaration 2006



ESOP Declaration 2000

The International Society of Oncology (ISOPP) exists since1996 and we are its European members. At the biannual ISOPP congress in Prague, April 2000, delegates of 17 European countries decided to initiate a European chapter of the ISOPP, the European Society of Oncology Pharmacy (ESOP).

It is predominantly the discussion that we have had in the past, about standardisation, certification and specialisation within the oncological pharmaceutical services, that unifies us. The effort to obtain collective answers to the above questions, especially in Europe, is starting to show results. Regarding the fact, that the situation of the oncology patient must be viewed upon as a whole, and that his needs and desires play an important factor we are aware that focusing on the cytostatic treatment alone is not enough we realise, that we also need to focus on a variety of other things, such as the appropriate diet, an adequate analgesic medication and the correct anti-emetic scheme We understand that we cannot ignore the social and psychological problems that the patient may experience by his or her situation.

In view of the fact that the financial resources have become limited, it has become necessary to intensify our pharmaceutical service, in order to increase cost effectiveness, to help ensure the adequate medical treatment and to prevent quality loss.

Here we can apply the following instruments:

Epidemiology

Chronopharmacology

Pharmacoeconomy

Pharmaceutical care

By this we achieve the goals of the ISOPP:

Aims

The aim of the society will be to determine the optimal medical treatment for cancer patients, thereby improving their quality of life.

Objectives


To promote clinical practice, research and development in drug use and administration for the treatment of cancer patients.

Europe is developing into a nation (continent) that behaves like a melting pot for all different cultures. However Europe can only act unified if the needs and differences of each country is respected, and here the regional factors as well as the language play a role.

Unity in diversity is one motto of the ISOPP. How typical is this for Europe?

It is the goal of ESOP to bring the aims of ISOPP, whose members we all are, closer to the Europeans living in Europe.



"Copernicus Agenda"
English German French
Czech Swedish Poland
Greek Slovenia  
Slovenia Netherlands Slowacien Republic Sweden Switzerland Czech Republic Luxembourg Austria Belgium Poland Portugal Italy Spain Cyprus Denmark Egypt France Germany Great Britain Romania Russia Vietnam Serbia Macedonia Malta Turkey Lithuania Iceland India Hungary Greece Estonia Bosnia Herzegowina Montenegro Morocco China Bulgaria Croatia Ireland Finnland Kosovo Kazakhstan Latvia League of Arab States